Skip to main content

Select Drug Profiles

Payer Coverage in Polycythemia Vera

Ken Schaecher, MD

Optimal Value-Based Therapy

Ken Schaecher, MD

Costs of Treatment in Polycythemia Vera

Ken Schaecher, MD

Payer Tools for Patient Care

Ken Schaecher, MD

Managing Oncology Costs in Polycythemia Vera

Ken Schaecher, MD

Affordable High Quality Care for Patients

Ken Schaecher, MD

Personalized Medicine: Are We There Yet?

David B. Nash, MD, MBA

Rewarding Innovation in Drug Development

Emily Saadi, Greg White, MPP

Original Research

Evaluation of Dabigatran for Appropriateness of Use and Bleeding Events in a Community Hospital Setting

Anastasia L Armbruster, PharmD, BCPS, Katie S Buehler, PharmD, BCPS, Sun H Min, PharmD, Margaret Riley, PharmD, Michael W Daly, PharmD, MSCI, BCPS

Stakeholder Perspective

Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation

by Raymond L. Singer, MD, MMM, CPE

Original Research

Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer

Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA

Stakeholder Perspective

Predicting Behavior: It’s a Matter of Preference

by Albert Tzeel, MD, MHSA, CPE, FAAPL

Page 143 of 244
Results 1421 - 1430 of 2434